Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 353 | 10,386 | 0 | 10,455 | 422 |
| Gross Profit | 353 | 10,386 | N/A | 10,455 | 422 |
| Operating Expenses | 55,272 | 56,790 | 34,015 | 26,366 | 23,400 |
| Operating Income | -54,919 | -46,404 | -34,015 | -15,911 | -22,978 |
| Other Income | 4,522 | 1,061 | 238 | -319 | -785 |
| Pre-tax Income | -50,397 | -45,343 | -33,777 | -16,230 | -23,763 |
| Net Income Continuous | -50,397 | -45,343 | -33,777 | -16,230 | -23,763 |
| Minority Interests | -8 | -5 | -9 | -6 | -160 |
| Net Income | $-50,389 | $-45,338 | $-33,768 | $-16,224 | $-23,603 |
| EPS Basic Total Ops | -0.94 | -1.60 | -1.77 | -1.77 | -7.03 |
| EPS Basic Continuous Ops | -0.94 | -1.60 | -1.77 | -1.77 | -7.08 |
| EPS Diluted Total Ops | -0.94 | -1.60 | -1.77 | -1.77 | -7.03 |
| EPS Diluted Continuous Ops | -0.94 | -1.60 | -1.77 | -1.77 | -7.08 |
| EPS Diluted Before Non-Recurring Items | -0.94 | -1.60 | -1.77 | -1.77 | -7.03 |
| EBITDA(a) | $-55,349 | $-44,176 | $-32,345 | $-14,189 | $-21,189 |